FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100025372> ?p ?o ?g. }

• W2100025372 endingPage "782" @default.
• W2100025372 startingPage "771" @default.
• W2100025372 abstract "Detection of minimal residual disease (MRD) is the most sensitive method to evaluate treatment response and one of the strongest predictors of outcome in childhood acute lymphoblastic leukemia (ALL). The 10-year update on the I-BFM-SG MRD study 91 demonstrates stable results (event-free survival), that is, standard risk group (MRD-SR) 93%, intermediate risk group (MRD-IR) 74%, and high risk group (MRD-HR) 16%. In multicenter trial AIEOP-BFM ALL 2000, patients were stratified by MRD detection using quantitative PCR after induction (TP1) and consolidation treatment (TP2). From 1 July 2000 to 31 October 2004, PCR target identification was performed in 3341 patients: 2365 (71%) patients had two or more sensitive targets (⩽10−4), 671 (20%) patients revealed only one sensitive target, 217 (6%) patients had targets with lower sensitivity, and 88 (3%) patients had no targets. MRD-based risk group assignment was feasible in 2594 (78%) patients: 40% were classified as MRD-SR (two sensitive targets, MRD negativity at both time points), 8% as MRD-HR (MRD ⩾10−3 at TP2), and 52% as MRD-IR. The remaining 823 patients were stratified according to clinical risk features: HR (n=108) and IR (n=715). In conclusion, MRD-PCR-based stratification using stringent criteria is feasible in almost 80% of patients in an international multicenter trial." @default.
• W2100025372 created "2016-06-24" @default.
• W2100025372 creator A5006790084 @default.
• W2100025372 creator A5011842227 @default.
• W2100025372 creator A5012680652 @default.
• W2100025372 creator A5020812442 @default.
• W2100025372 creator A5023918175 @default.
• W2100025372 creator A5036133509 @default.
• W2100025372 creator A5038604161 @default.
• W2100025372 creator A5039182891 @default.
• W2100025372 creator A5043116632 @default.
• W2100025372 creator A5051520180 @default.
• W2100025372 creator A5051981929 @default.
• W2100025372 creator A5056686915 @default.
• W2100025372 creator A5059892396 @default.
• W2100025372 creator A5060642289 @default.
• W2100025372 creator A5075351116 @default.
• W2100025372 creator A5076365826 @default.
• W2100025372 creator A5076557705 @default.
• W2100025372 creator A5083575870 @default.
• W2100025372 creator A5090678844 @default.
• W2100025372 creator A5091266131 @default.
• W2100025372 date "2008-01-31" @default.
• W2100025372 modified "2023-10-12" @default.
• W2100025372 title "Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia" @default.
• W2100025372 cites W11202050 @default.
• W2100025372 cites W1209942950 @default.
• W2100025372 cites W1490840859 @default.
• W2100025372 cites W1520987166 @default.
• W2100025372 cites W1593699854 @default.
• W2100025372 cites W1976591956 @default.
• W2100025372 cites W1977632364 @default.
• W2100025372 cites W1982357299 @default.
• W2100025372 cites W1986395681 @default.
• W2100025372 cites W1989261632 @default.
• W2100025372 cites W2004153775 @default.
• W2100025372 cites W2007208181 @default.
• W2100025372 cites W2020094108 @default.
• W2100025372 cites W2020206419 @default.
• W2100025372 cites W2023331249 @default.
• W2100025372 cites W2033439695 @default.
• W2100025372 cites W2039677781 @default.
• W2100025372 cites W2041469840 @default.
• W2100025372 cites W2045991264 @default.
• W2100025372 cites W2047105950 @default.
• W2100025372 cites W2054098724 @default.
• W2100025372 cites W2054629719 @default.
• W2100025372 cites W2057388030 @default.
• W2100025372 cites W2063286298 @default.
• W2100025372 cites W2068835290 @default.
• W2100025372 cites W2069085828 @default.
• W2100025372 cites W2069904949 @default.
• W2100025372 cites W2070173503 @default.
• W2100025372 cites W2070434896 @default.
• W2100025372 cites W2071899049 @default.
• W2100025372 cites W2079442847 @default.
• W2100025372 cites W2087111337 @default.
• W2100025372 cites W2090396822 @default.
• W2100025372 cites W2090823859 @default.
• W2100025372 cites W2091454369 @default.
• W2100025372 cites W2095893307 @default.
• W2100025372 cites W2102067583 @default.
• W2100025372 cites W2109388187 @default.
• W2100025372 cites W2113670242 @default.
• W2100025372 cites W2118457944 @default.
• W2100025372 cites W2123683190 @default.
• W2100025372 cites W2127370636 @default.
• W2100025372 cites W2134091917 @default.
• W2100025372 cites W2151069914 @default.
• W2100025372 cites W2153400118 @default.
• W2100025372 cites W2159325547 @default.
• W2100025372 cites W2160687591 @default.
• W2100025372 cites W2170258491 @default.
• W2100025372 cites W2313577290 @default.
• W2100025372 cites W4375906968 @default.
• W2100025372 cites W59733412 @default.
• W2100025372 doi "https://doi.org/10.1038/leu.2008.5" @default.
• W2100025372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18239620" @default.
• W2100025372 hasPublicationYear "2008" @default.
• W2100025372 type Work @default.
• W2100025372 sameAs 2100025372 @default.
• W2100025372 citedByCount "328" @default.
• W2100025372 countsByYear W21000253722012 @default.
• W2100025372 countsByYear W21000253722013 @default.
• W2100025372 countsByYear W21000253722014 @default.
• W2100025372 countsByYear W21000253722015 @default.
• W2100025372 countsByYear W21000253722016 @default.
• W2100025372 countsByYear W21000253722017 @default.
• W2100025372 countsByYear W21000253722018 @default.
• W2100025372 countsByYear W21000253722019 @default.
• W2100025372 countsByYear W21000253722020 @default.
• W2100025372 countsByYear W21000253722021 @default.
• W2100025372 countsByYear W21000253722022 @default.
• W2100025372 countsByYear W21000253722023 @default.
• W2100025372 crossrefType "journal-article" @default.
• W2100025372 hasAuthorship W2100025372A5006790084 @default.
• W2100025372 hasAuthorship W2100025372A5011842227 @default.
• W2100025372 hasAuthorship W2100025372A5012680652 @default.

• next